Coherus Oncology (CHRS) Current Assets (2013 - 2026)
Coherus Oncology (CHRS) recorded Current Assets of $133.79 million in Q2 2026, down 64.8% from $380.21 million a year earlier and down 35.1% from the prior quarter.
Coherus Oncology (CHRS) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology reported Current Assets of $206.71 million, down 39.5% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -23.1% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $341.58 million in FY2024 (-28.2%), $475.63 million in FY2023 (+24.8%), $381.23 million in FY2022 (-36.7%) and $602.32 million in FY2021 (-21.5%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q4 2018.
- On a year-over-year basis, Current Assets has declined for three consecutive quarters, with an average decline of 30.1% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 98.6% in Q1 2024, against a decline of 64.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $206.04 million (Q1 2026), $206.71 million (Q4 2025) and $460.96 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn | 133.79 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133.79 Mn |
| Mar 31, 2026 | 206.04 Mn |
| Dec 31, 2025 | 206.71 Mn |
| Sep 30, 2025 | 460.96 Mn |
| Jun 30, 2025 | 380.21 Mn |
| Mar 31, 2025 | 310.18 Mn |
| Dec 31, 2024 | 341.58 Mn |
| Sep 30, 2024 | 369.02 Mn |
| Jun 30, 2024 | 557.93 Mn |
| Mar 31, 2024 | 627.48 Mn |
| Dec 31, 2023 | 475.63 Mn |
| Sep 30, 2023 | 444.37 Mn |
| Jun 30, 2023 | 385.48 Mn |
| Mar 31, 2023 | 315.93 Mn |
| Dec 31, 2022 | 381.23 Mn |
| Sep 30, 2022 | 448.28 Mn |
| Jun 30, 2022 | 446.78 Mn |
| Mar 31, 2022 | 512.44 Mn |
| Dec 31, 2021 | 602.32 Mn |
| Sep 30, 2021 | 673.04 Mn |
Coherus Oncology Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CHRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();